Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides high quality oligonucleotides for use in next generation sequencing (NGS).
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides high quality oligonucleotides for use in next generation sequencing (NGS).
When used as adapters, these oligonucleotides can be designed to incorporate unique Hamming error-correction that maximizes the accuracy of barcoding individual samples.
In the most recent edition of IDT's quarterly newsletter, DECODED, Ellen Prediger, Director of Scientific Communications at IDT, discusses work carried out by Dr Shengdar Tsai who used IDT oligos that take advantage of Hamming barcoding to create multiplexed next generation sequencing libraries.
While a graduate student in the lab of Dr Jorge Piedrahita at North Carolina State University, Dr Tsai performed multiplexed targeted sequence capture to investigate mutations associated with fetal growth restriction, a dangerous pregnancy-related condition that is the second leading cause of prenatal death.
To find out more about this story and discover a whole host of additional useful information, download the latest version of Decoded from the IDT website now.
